| Period Ending | Dec 31, 2011 | Dec 31, 2010 | Dec 31, 2009 | Dec 31, 2008 |
|---|
|
Total Revenue
|
20,084,000
|
15,680,000
|
10,640,000
|
11,192,000
| | Cost of Revenue | 16,255,000 | 12,578,000 | 8,305,000 | 8,829,000 | | |
Gross Profit
|
3,829,000
|
3,102,000
|
2,336,000
|
2,363,000
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative |
-
|
-
|
-
|
-
|
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses | 17,730,000 | 13,431,000 | 9,315,000 | 10,041,000 | | | |
Operating Income or Loss
|
2,353,000
|
2,249,000
|
1,325,000
|
1,151,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net |
-
|
-
|
-
|
-
|
|
Earnings Before Interest And Taxes | 2,353,000 | 2,249,000 | 1,325,000 | 1,151,000 |
|
Interest Expense | (75,000) | (48,000) | (45,000) | (52,000) |
|
Income Before Tax |
-
|
-
|
-
|
-
|
|
Income Tax Expense | 583,000 | 583,000 | 398,000 | 367,000 |
|
Minority Interest | (1,413,000) | (1,300,000) | (701,000) | (615,000) |
|
|
|
Net Income From Continuing Ops | 2,443,000 | 2,244,000 | 1,213,000 | 1,063,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
1,030,000
|
944,000
|
512,000
|
448,000
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
-
|
-
|
-
|
-
|
|
0.09%